Why use of dienogest for the first contraceptive pill with estradiol?
- 8 December 2009
- journal article
- other
- Published by Taylor & Francis Ltd in Gynecological Endocrinology
- Vol. 26 (2), 109-113
- https://doi.org/10.3109/09513590903184167
Abstract
Dienogest (DNG) has the essential properties of an effective progestogen for use in a new contraceptive pill using estradiol valerate as estrogenic component -- it inhibits ovulation and protects against endometrial proliferation. DNG is a derivative of norethisterone (NET), but has a cyanomethyl- instead of an ethinyl-group in C17 position which may offer a variety of benefits regarding hepatic effects. The similarity to NET is reflected in the high endometriotropy and in similar pharmacokinetics like short plasma half-live and high bioavailability. However, DNG also elicits properties of progesterone derivatives like neutrality in metabolic and cardiovascular system and considerable antiandrogenic activity, the latter increased by lack of binding to SHBG as specific property of DNG. It has no glucocorticoid and antimineralocorticoid activity and has no antiestrogenic activity with the consequence that possible beneficial estradiol effects should not be antagonized. This may be of special importance for the tolerability and safety of the first pill with estradiol valerate instead of ethinylestradiol, although well-designed postmarketing studies are still ongoing to demonstrate what can be expected on the basis of pharmacology.Keywords
This publication has 16 references indexed in Scilit:
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profileSteroids, 2008
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosisGynecological Endocrinology, 2006
- Biochemical markers surrogating on vascular effects of sex steroid hormonesGynecological Endocrinology, 2006
- Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptivesContraception, 2004
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized studyFertility and Sterility, 2002
- Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogestMaturitas, 2001
- What is past is prologue: estrogen/progestin replacement tomorrowGynecological Endocrinology, 2001
- Pharmacokinetics of Estradiol Valerate 2mg + Dienogest 2mg (Climodien?? 2/2) after Single and Repeated Oral Administration in Healthy Postmenopausal WomenClinical Drug Investigation, 2000
- Inhibition of oral contraceptive steroid—metabolizing enzymes by steroids and drugsAmerican Journal of Obstetrics and Gynecology, 1990
- Pharmacokinetics of oestrogens and progestogensMaturitas, 1990